Healthcare
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
It’s been a long road for medical device manufacturer ImpediMed, but analysts believe the company is now ready to increase scale
Dec 16 2025
Fisher & Paykel Healthcare’s first half saw lower costs overcoming a drag from US tariffs. Declining US vaccination rates could provide a boost in the second half
Dec 02 2025
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| 4DX | $2.98 | $3.04 | $0.23 | $2.20 | ||
| ACL | $2.78 | $3.83 | $2.38 | $3.20 | ||
| ALC | $0.11 | $0.14 | $0.06 | $0.14 | ||
| ARX | AROA BIOSURGERY LIMITED | $0.66 | $0.82 | $0.35 | 132.8 | $0.82 |
| AVH | AVITA MEDICAL INC | $1.02 | $4.52 | $1.00 | $1.275 | |
| BIO | $0.40 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| BMT | $0.20 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CAT | CATAPULT SPORTS LIMITED | $4.21 | $xx.xx | $xx.xx | xx.x | xx.xx |
| COH | COCHLEAR LIMITED | $260.91 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CSL | CSL LIMITED | $177.15 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CU6 | $2.92 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CUV | $12.58 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| CVB | CURVEBEAM AI LIMITED | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CYC | CYCLOPHARM LIMITED | $1.00 | $xx.xx | $xx.xx | xx.x | xx.xx |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $0.12 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBO | EBOS GROUP LIMITED | $24.00 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBR | EBR SYSTEMS INC | $0.87 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EGH | EUREKA GROUP HOLDINGS LIMITED | $0.48 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EMV | $1.77 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $32.91 | $xx.xx | $xx.xx | xx.x | xx.xx |
| GSS | GENETIC SIGNATURES LIMITED | $0.24 | $xx.xx | $xx.xx | xx.x | xx.xx |
| HLS | HEALIUS LIMITED | $0.98 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $2.48 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IME | IMEXHS LIMITED | $0.33 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMM | IMMUTEP LIMITED | $0.37 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMR | IMRICOR MEDICAL SYSTEMS INC | $1.44 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMU | $0.32 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| INA | INGENIA COMMUNITIES GROUP | $5.11 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | IMPEDIMED LIMITED | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx |
| LIC | $5.37 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| M7T | MACH7 TECHNOLOGIES LIMITED | $0.56 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MAP | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MPL | MEDIBANK PRIVATE LIMITED | $4.79 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MSB | MESOBLAST LIMITED | $2.77 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVF | MONASH IVF GROUP LIMITED | $0.82 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVP | $0.52 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| MX1 | MICRO-X LIMITED | $0.08 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NAN | NANOSONICS LIMITED | $4.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NEU | NEUREN PHARMACEUTICALS LIMITED | $19.50 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NHF | NIB HOLDINGS LIMITED | $6.92 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NUZ | $0.11 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| OCA | OCEANIA HEALTHCARE LIMITED | $0.78 | $xx.xx | $xx.xx | xx.x | xx.xx |
| ONE | ONEVIEW HEALTHCARE PLC | $0.35 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PAR | $0.30 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PGC | PARAGON CARE LIMITED | $0.26 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PME | $226.05 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| PNV | POLYNOVO LIMITED | $1.17 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PYC | PYC THERAPEUTICS LIMITED | $1.49 | $xx.xx | $xx.xx | xx.x | xx.xx |
| REG | $7.37 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| RHC | RAMSAY HEALTH CARE LIMITED | $34.90 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $38.18 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SHL | SONIC HEALTHCARE LIMITED | $22.98 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SNT | $0.03 | $xx.xx | $xx.xx | xx.x | xx.xx | |
| SOM | SOMNOMED LIMITED | $0.77 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TLX | TELIX PHARMACEUTICALS LIMITED | $12.56 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | $0.67 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
4DMedical Poised For A Recovery
Nov 25 2025
Michael Gable of Fairmont Equities notes 4DMedical shares retraced from a new October high and the bounce supports a move higher
Treasure Chest: Pro Medicus
Nov 12 2025
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Pro Medicus
Tariff Uncertainty Negates ResMed’s Q1 Positives
Nov 05 2025
ResMed’s first-quarter result broadly met market expectations, though rising margins and potential for further capital management have been negated by US import tariff ambiguity
Anti-Vaxxers & China Cloud CSL’s Future
Oct 31 2025
Falling vaccination rates in the US prompted a guidance downgrade at CSL, but was the market’s reaction excessive?
Rudi Interviewed: Diary Of A Successful Investor
Oct 20 2025
FNArena Editor Rudi Filapek-Vandyck was interviewed by Peter Switzer as the opening act in a new series titled The Diary of a Successful Investor
Acquisition Loads Up Catapult
Oct 20 2025
In its latest acquisition, Catapult Sports has added the missing element to make it a globally competitive sports software company
Is CSL Starting Its Price Recovery?
Sep 30 2025
As bruised CSL shareholders would attest to, the biotech has been challenged. Fairmont Equities’ Michael Gable reports signs of a turnaround are in place
Undervalued ASX Gems In Precision Medicine
Sep 23 2025
Flighty investors have caused share prices to fall in 2025, but MPC Markets’ Mark Gardner sees better futures ahead for two ASX-listed companies involved in cancer prevention and treatment
Earnings Result Leaves CSL Bloodied
Aug 21 2025
Uncertain Behring growth, lower vaccine sales and a controversial restructuring plan led to a post-result share price drubbing. Is it all over for CSL?
Cochlear’s Future In Nexa’s Hands
Aug 19 2025
Following a weak FY25, and weak FY26 guidance, Cochlear’s outlook rests on the success of its new Nexa implant and other products. Is the market too confident?
Latest News
| 1 | Crude Oil: What’s next?11:18 AM - Commodities |
| 2 | ASIC Watch: 2026 Priorities Target Private Credit & Unlisted Asset Opacity11:00 AM - Australia |
| 3 | Technical Views On Nasdaq, ASX200 & Oil10:30 AM - Technicals |
| 4 | COG Financial Firing On All Cylinders10:00 AM - Small Caps |
| 5 | The Overnight Report: Nasdaq Up, Oil Down8:50 AM - Daily Market Reports |